Tehran University of Medical Sciences

Science Communicator Platform

Share By
Development of New Coumarin-Piperazine-N-Phenylacetamid Derivatives As Potent Tyrosinase Inhibitors: In Vitro and in Silico Evaluations Publisher



Aghanour Ashtiani MM ; Karimian S ; Iraji A ; Dastyafteh N ; Mohammadikhanaposhtani M ; Larijani B ; Mahdavi M ; Salehi P
Authors

Source: Medicinal Chemistry Research Published:2026


Abstract

Inhibiting tyrosinase is critical for managing pigmentation disorders and preventing enzymatic browning in food and crops. In this research, a series of novel hybrid coumarin- piperazine-N-phenylacetamide derivatives 11a-q were designed and synthesized to inhibit tyrosinase. The structural identification of compounds 11a-q was carried out using spectroscopic methods, including FTIR, 1H-NMR, and 13C-NMR. The inhibitory activity of these compounds against mushroom tyrosinase and their antioxidant properties were evaluated in vitro. All derivatives showed inhibitory effects on tyrosinase at a concentration of 200 µM, and among them, compound 11 L with an IC50 value of 176.65 µM exhibited the highest activity. Also, at this concentration, all compounds showed weak antioxidant activity. In addition, molecular docking and molecular dynamics studies were performed to investigate the type and energy of interactions of compound 11 L with the active site of the active site of the tyrosinase. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2026.
Other Related Docs